This month, our CMO, Prof. dr. Jorrit-Jan Verlaan, was invited to the Washington Health Innovation Council Florida Summit to discuss how surgical pain blockers can reduce opioid exposure at known entry points for long-term opioid use, helping patients benefit from surgery without the added risks of dependence.

Many thanks to the organizers and all participants for an insightful and forward-looking discussion.